Markus Renschler

Insider Reports History

Entity
Individual
Location
C/O Pharmacyclics Inc, 995 E Arques Ave, Sunnyvale, CA
Signature
/s/ David Gaiero, as attorney-in-fact for Markus Renschler, M.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Markus Renschler:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cyteir Therapeutics, Inc. President and CEO, Director Common Stock 1.1M $1.87M $1.69 Mar 4, 2024 Direct
Cyteir Therapeutics, Inc. President and CEO, Director Stock Option (Right to Buy) 221K Mar 4, 2024 Direct

Insider Reports Filed by Markus Renschler

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CYT Cyteir Therapeutics, Inc. Feb 29, 2024 6 $35K 4 Mar 5, 2024 President and CEO, Director
CYT Cyteir Therapeutics, Inc. Dec 11, 2023 4 $13.7K 4 Dec 14, 2023 President and CEO, Director
CYT Cyteir Therapeutics, Inc. Nov 20, 2023 4 $129K 4 Nov 22, 2023 President and CEO, Director
CYT Cyteir Therapeutics, Inc. Feb 3, 2023 2 $7.45K 4 Feb 7, 2023 President and CEO, Director
CYT Cyteir Therapeutics, Inc. Dec 21, 2022 4 $146K 4 Dec 23, 2022 President and CEO, Director
CYT Cyteir Therapeutics, Inc. Feb 22, 2022 1 $0 4 Feb 24, 2022 President and CEO, Director
CYT Cyteir Therapeutics, Inc. Jun 17, 2021 0 $0 3 Jun 17, 2021 President and Chief Executive Officer Exhibit List: Exhibit 24 - Power of Attorney, Director